Wockhardt gets US FDA nod for augmentin
MUMBAI (Reuters) - Wockhardt Ltd said on Thursday its U.S. subsidiary, Morton Grove Pharmaceuticals, received US FDA approval to market augmentin suspension, a pediatric drug.
The drug is used to treat several common infections, especially in children. The company intends to launch the product in the U.S in the third quarter of 2009, it said in a statement.
© Thomson Reuters 2010 All rights reserved
Economy seen growing at 7.2 pct in FY10 - govt
The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget. Full Article
Greek crisis sets euro zone enlargement back
The Greek debt crisis has dealt a setback to prospects of enlarging the euro zone by highlighting the difficulties of managing the single currency area. Full Article
India
US
UK
